{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:56:36Z","timestamp":1790546196568,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102020804"],"award-info":[{"award-number":["202102020804"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e33015","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T12:59:22Z","timestamp":1718801962000},"page":"e33015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel envelope protein time-resolved fluoroimmunoassay as an alternative in vitro potency assay for quality control of inactivated Japanese encephalitis virus vaccine"],"prefix":"10.1016","volume":"10","author":[{"given":"Zhaoyue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-9625","authenticated-orcid":false,"given":"Guanfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e33015_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4269\/ajtmh.23-0036","article-title":"Japanese encephalitis among adults: a review","volume":"108","author":"Hills","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e33015_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010361","article-title":"Estimates of Japanese Encephalitis mortality and morbidity: a systematic review and modeling analysis","volume":"16","author":"Cheng","year":"2022","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e33015_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2023.105433","article-title":"The spatial-temporal pattern of Japanese encephalitis and its influencing factors in Guangxi, China","volume":"111","author":"Li","year":"2023","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.heliyon.2024.e33015_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v14122686","article-title":"Molecular mechanism and role of Japanese encephalitis virus infection in central nervous system-mediated diseases","volume":"14","author":"Yadav","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2024.e33015_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s43440-022-00355-2","article-title":"Antiviral drug research for Japanese encephalitis: an updated review","volume":"74","author":"Joe","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.heliyon.2024.e33015_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11040742","article-title":"Japanese encephalitis virus: an update on the potential antivirals and vaccines","author":"Srivastava","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.heliyon.2024.e33015_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11908-022-00786-1","article-title":"Interventions for the prevention and treatment of Japanese encephalitis","volume":"24","author":"Sahu","year":"2022","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.heliyon.2024.e33015_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","article-title":"Japanese encephalitis \u2014 the prospects for new treatments","volume":"14","author":"Turtle","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.heliyon.2024.e33015_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11030317","article-title":"Japanese encephalitis virus interaction with mosquitoes: a review of vector competence, vector capacity and mosquito immunity","volume":"11","author":"Van den Eynde","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.heliyon.2024.e33015_bib10","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/j.vaccine.2021.06.023","article-title":"Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: a systematic review and network meta-analysis","volume":"39","author":"Furuya-Kanamori","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e33015_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41541-021-00338-z","article-title":"The Japanese encephalitis vaccination experts, the future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control","volume":"6","author":"Vannice","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.heliyon.2024.e33015_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2022.114540","article-title":"Comparison of plaque reduction and focus reduction neutralization tests for the measurement of neutralizing antibody titers against Japanese encephalitis virus","volume":"306","author":"Park","year":"2022","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.heliyon.2024.e33015_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4149\/av_2015_03_234","article-title":"Standardization of serum neutralization assay of Japanese encephalitis virus (Nakayama NIH strain) on BHK-21 (Cl-13) cell line","volume":"59","author":"Singh","year":"2015","journal-title":"Acta Virol."},{"key":"10.1016\/j.heliyon.2024.e33015_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/14760584.2023.2178421","article-title":"Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays","volume":"22","author":"Zhang","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.heliyon.2024.e33015_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104492","article-title":"The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus","volume":"148","author":"Leng","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.heliyon.2024.e33015_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/v14122640","article-title":"Contrasting the practices of virus isolation and characterization between the early period in history and modern times: the case of Japanese encephalitis virus","volume":"14","author":"Kuno","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2024.e33015_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.micpath.2017.08.046","article-title":"Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: probable association of mutation in amino acid of its envelope protein","volume":"111","author":"Nath","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.heliyon.2024.e33015_bib18","article-title":"Genomic characteristics and E protein bioinformatics analysis of JEV isolates from south China from 2011 to 2018","volume":"10","author":"Sun","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.heliyon.2024.e33015_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virusres.2016.07.012","article-title":"A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine","volume":"223","author":"Kim","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.heliyon.2024.e33015_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124903","article-title":"Single-molecule immunoassay technology: recent advances","volume":"265","author":"Wu","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.heliyon.2024.e33015_bib21","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1038\/s41598-017-07687-7","article-title":"A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e33015_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jviromet.2014.06.002","article-title":"A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine","volume":"206","author":"Lin","year":"2014","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.heliyon.2024.e33015_bib23","article-title":"Development of an in vitro test method to replace an animal-based potency test for pertactin antigen in multivalent vaccines","volume":"11","author":"Szeto","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.heliyon.2024.e33015_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4269\/ajtmh.19-0073","article-title":"A monoclonal antibody specific for Japanese encephalitis virus with high neutralizing capability for inclusion as a positive control in diagnostic neutralization tests","volume":"101","author":"Calvert","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.heliyon.2024.e33015_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12026-020-09130-y","article-title":"Structural and molecular analyses of functional epitopes and escape mutants in Japanese encephalitis virus envelope protein domain III","volume":"68","author":"Roy","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.heliyon.2024.e33015_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111826","article-title":"Immunological analysis of nodavirus capsid displaying the domain III of Japanese encephalitis virus envelope protein","volume":"13","author":"Kumar","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e33015_bib27","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1016\/j.vaccine.2021.10.060","article-title":"A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine","volume":"39","author":"Ye","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2024.e33015_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biologicals.2020.08.008","article-title":"A time-resolved fluoroimmunoassay for assessing rabies antibody titers in the sera of vaccinated human subjects","volume":"68","author":"Bian","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.heliyon.2024.e33015_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2023.114752","article-title":"A custom-made time-resolved fluoroimmunoassay for the quantitation of the host cell protein of Vero in rabies vaccine","volume":"318","author":"Yang","year":"2023","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.heliyon.2024.e33015_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1348-0421.2012.00462.x","article-title":"Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine","volume":"56","author":"Kim","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.heliyon.2024.e33015_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113179","article-title":"Development of a time-resolved fluorescence immunoassay based on immunomagnetic beads for gastrin-17","volume":"499","author":"Zheng","year":"2021","journal-title":"J. Immunol. Methods"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:03:57Z","timestamp":1790543037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024090467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024090467"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33015","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel envelope protein time-resolved fluoroimmunoassay as an alternative in vitro potency assay for quality control of inactivated Japanese encephalitis virus vaccine","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33015"}}